Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShare-based Compensation (IS)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

CureVac N.V (CVAC) Cost of Revenue: 2018-2024

Historic Cost of Revenue for CureVac N.V (CVAC) over the last 7 years, with Dec 2024 value amounting to $113.1 million.

  • CureVac N.V's Cost of Revenue fell 94.29% to $2.5 million in Q2 2025 from the same period last year, while for Jun 2025 it was $29.1 million, marking a year-over-year decrease of 83.20%. This contributed to the annual value of $113.1 million for FY2024, which is 15.49% down from last year.
  • According to the latest figures from FY2024, CureVac N.V's Cost of Revenue is $113.1 million, which was down 15.49% from $133.8 million recorded in FY2023.
  • CureVac N.V's Cost of Revenue's 5-year high stood at $272.5 million during FY2021, with a 5-year trough of $16.9 million in FY2020.
  • For the 3-year period, CureVac N.V's Cost of Revenue averaged around $144.9 million, with its median value being $133.8 million (2023).
  • Per our database at Business Quant, CureVac N.V's Cost of Revenue plummeted by 45.44% in 2020 and then surged by 1,512.52% in 2021.
  • CureVac N.V's Cost of Revenue (Yearly) stood at $16.9 million in 2020, then surged by 1,512.52% to $272.5 million in 2021, then plummeted by 31.11% to $187.7 million in 2022, then decreased by 28.72% to $133.8 million in 2023, then decreased by 15.49% to $113.1 million in 2024.